We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+16.5%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$570M
AUM Growth
+$32M
Cap. Flow
+$8.01M
Cap. Flow %
1.4%
Top 10 Hldgs %
66.95%
Holding
31
New
4
Increased
5
Reduced
8
Closed
5

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$42.6M
2
EXAS
Exact Sciences
EXAS
+$23.3M
3
INSM icon
Insmed
INSM
+$19.9M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$19.3M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$9.6M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$28.4M
2
TMDX icon
Transmedics
TMDX
+$17.5M
3
NTRA icon
Natera
NTRA
+$16.1M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$13.4M
5
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$12.4M

Sector Composition

Rank Sector Weight
1 Healthcare 98.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRAL
26
GRAIL Inc
GRAL
$3.34B
$817K 0.14%
+53,124
New +$862K
DHR icon
27
Danaher
DHR
$146B
– –
-113,685
Closed -$28.4M
PACB icon
28
Pacific Biosciences
PACB
$361M
– –
-2,167,021
Closed -$8.13M
SRPT icon
29
Sarepta Therapeutics
SRPT
$1.9B
– –
-103,256
Closed -$13.4M
TXG icon
30
10x Genomics
TXG
$7.72B
– –
-135,059
Closed -$5.07M
FUSN
31
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
– –
-579,769
Closed -$12.4M
1
2

Similar funds

IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return
GP
GSK plc London $599M AUM

Eagle Health Investments's Q2 2024 Portfolio in Review

As of Q2 2024, Eagle Health Investments held 31 positions worth $570M, up 5.9% from $538M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Eagle Health Investments's Q2 2024 filing shows 4 new, 5 increased, 8 reduced and 5 closed positions. Its largest new stake was UnitedHealth: 86,900 shares worth $44.3M. The largest sale was Danaher, an estimated $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 98% a quarter earlier.

  • Eagle Health Investments's largest Q2 2024 buy was UnitedHealth: 86,900 shares worth $44.3M.
  • Eagle Health Investments added most to Exact Sciences in Q2 2024, an estimated $23.3M increase.
  • Eagle Health Investments's biggest Q2 2024 reduction was Transmedics, cutting an estimated $17.5M.
  • Eagle Health Investments fully exited Danaher in Q2 2024, selling an estimated $28.4M.
  • Eagle Health Investments's ten largest holdings make up 67% of its $570M portfolio in Q2 2024.
  • Eagle Health Investments opened 4 new positions and closed 5 in Q2 2024.
  • Eagle Health Investments's portfolio value rose 5.9% quarter-over-quarter to $570M.

Based on Eagle Health Investments's 13F filing for Q2 2024, filed 13 Aug 2024.